Biotech News

Recursion to Participate in Upcoming Investor Conferences

Recursion (RXRX)RecursionCompany update

Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today announced its participation in the following upcoming investor conferences:

Related news

Recursion

AI-Native Drug Discovery Recursion is a clinical-stage TechBio company using an integrated discovery and development platform to generate medicines across oncology, rare disease, neuroscience and immunology. The Recursion OS combines proprietary multimodal biological and chemical data, purpose-built AI models and experimental...

Recent company news

Stock data

Close
2.72 USD
Market cap
1.92B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States